@ExceptionalVen1 - Matt Cooper: 45+ longevity companies. @MaxwellBiosci's Scotch McClure: rejuvenation from hypothesis to clinic. @MaerkiBaumann: longevity as the allocation question of the decade.
Among the latest partners joining us in Gstaad this September.
https://t.co/OxSniE46yJ
The longevity funding leaderboard has changed.Altos Labs anchors at $5.56B. Retro Biosciences moved from $180M to $1.18B+ at $1.8B. Insilico Medicine completed the largest HK biotech IPO of the year, with Eli Lilly and Tencent as cornerstones. @newlimit : direct Lilly equity at $1.62B. @Oura ($11B), @function ($2.5B), Neko Health ($1.8B) entered the top ten.
Full analysis: https://t.co/dxXxbwCd6H #LIC2026
A panel on what it takes to build a longevity company to global scale, with four people who have done exactly that.
@zmudze. Masha Bucher. @annaskaya . @M_S_Ringel.
#LIC2026 · Gstaad · Application-only. Early Bird closes 31 May: https://t.co/Myw2nxd8bm
Twenty years studying the molecular mechanisms of aging. FMI, @Harvard , @ETH . Now developing regenerative pharmacological interventions at @Novartis Biomedical Research.
Dr. @CollinEwald joins #LIC2026 in Gstaad this September.
9 days left at Early Bird pricing. Apply: https://t.co/OxSniE46yJ
Dr. Adeel Khan was the first physician to combine multiple advanced cell therapies in clinical practice. Years before it became standard.
Stem cell technology, peptide therapy, regenerative medicine, precision diagnostics. Founder of Eterna Health.
The physician royalty, world champions, and figures like @TonyRobbins and @chrishemsworth choose.
Confirmed for #LIC2026: https://t.co/OxSniE46yJ
When investors ask "who decides where longevity capital goes next," @M_S_Ringel is on the short list.
COO at @lifebiosciences. Board, @hevolution_f US.
Confirmed for #LIC2026 in Gstaad this September.
Early Bird closes 31 May: https://t.co/Myw2nxd8bm
You can't fake operator pattern recognition.
Anna Skaya. Founder of Basepaws (exit to Zoetis, 2022). GP at AniVC. Board, Petco Foundation.
She joins #LIC2026 in Gstaad this September. Early Bird closes 31 May.
Apply: https://t.co/RFtaArlawg
You can't invest in what you can't measure.
Dr. Yi "Sherry" Zhang co-founded @HealthspanHorizons at @BuckInstitute, building the AI infrastructure for measurable healthspan.
Founder of @GenoPalate .
Operator + scientist.
She joins #LIC2026 in Gstaad this September.
Apply: https://t.co/GcpACRj9jk
The companies that have stood in front of our investors at LIC are still making waves.
@hacking_aging@cellcolabsclini
Deciduous Therapeutic
@MitoRxTheraLtd@glycanage
Major pharma deals. A $12M raise. Real momentum.
The Start-Up Innovation Catalyst 2026 is open. Applications close June 21.
Apply: https://t.co/bXcINgS96e
#LIC2026
The world's oldest people are rewriting what we thought we knew about human lifespan.
The science, the data, and the investment case behind extreme longevity research.
The 100-Year Blueprint: Investing in the Science of Extreme Longevity - @aubreydegrey & Natalie Coles
#LIC2026 | Gstaad, September 14-17.
Apply: https://t.co/GcpACRj9jk
#LongevityInvestors
The longevity market hits $8T by 2030. Surpassing AI.
@JeffBezos put $3B into @altos_labs Labs. Altman $180M into @RetroBio_ . Armstrong co-founded @newlimit at $5B valuation. Longevity investment doubled in one year.
Family offices are building this economy. Not just funding it.
LINews 👇 https://t.co/QkqSd5WCyq